Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?

ABSTRACT:

Background

The increased availability of patient reported outcome data makes it feasible to provide patients tailored risk information of cancer treatment side effects. However, it is unclear how such information influences patients' risk interpretations compared to generic population-based risks, and which message format should be used to communicate such individualized statistics.

Methods

A web-based experiment was conducted in which participants (n = 141) read a hypothetical treatment decision-making scenario about four side effect risks of adjuvant chemotherapy for advanced colon cancer. Participants were cancer patients or survivors who were recruited from an online Dutch cancer patient panel. All participants received two tailored risks (of which the reference class wa

SUBMITTER: Vromans RD 

PROVIDER: S-EPMC7590680 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature